Drug factory · FDA FEI 3006803926
bene pharmaChem GmbH & Co. KG
Bayerwaldstr. 7-9, Geretsried, Germany
Problems found, fixed voluntarily at FDA's last inspection, Nov 8, 2018.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
4 drug inspections on record since 2008: 1 with no problems, 3 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Pentosan Polysulfate | Makes the active ingredient | Janssen Pharmaceuticals, Inc. | 50458-098 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Nov 8, 2018 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| May 21, 2014 | No problems found | Drug Quality Assurance | — |
| Jul 8, 2011 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Oct 23, 2008 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
Registered with FDA for: api manufacture.